Peripheral Immunological Signatures of Parkinsonism: Insights from the Caribbean vs. North America
Authors:
- Hugo ChaumontHCHugo Chaumont
- Perrine CoqueletPCPerrine Coquelet
- Renaud BalthazardRBRenaud Balthazard
- Benoit TressièresBTBenoit Tressières
- Ariane Veilleux CarpentierACAriane Veilleux Carpentier
- Antoine DuquetteADAntoine Duquette
- Lovatiana AndriamboavonjyLALovatiana Andriamboavonjy
- Diana MatheoudDMDiana Matheoud
- Martine TétreaultMTMartine Tétreault
- 1 January 2026
- journal article
- research article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 63 (1) , 635
Abstract
The contribution of the peripheral immune system to Parkinson's disease (PD) and Atypical parkinsonism (AP), including multiple system atrophy, progressive supranuclear palsy, and Caribbean atypical parkinsonism, is increasingly recognized, albeit incompletely resolved. Our study aimed to compare the peripheral immunological profile of PD and AP patients from two distinct geographical areas, Guadeloupe and Montreal. We conducted a cross-sectional study on PD and AP patients and healthy controls from Guadeloupe and Montreal (total 57 subjects). We collected clinical assessments and arbovirus serologies. We performed an immune profiling of peripheral blood mononuclear cells by flow cytometry. Nearly all Guadeloupe subjects had prior exposure to an endemic arbovirus, while seropositivity was minimal in Montreal. Samples from the Guadeloupe cohort showed an increased proportion of γδ T cells and enhanced CD8+ T cell inflammatory properties, particularly in PD patients and healthy controls, compared to their Montreal counterparts. Specific memory B cell subsets were more abundant in Guadeloupe-PD and Guadeloupe-AP than in Montreal patients. The percentage of plasmablasts positively correlated with clinical scores in Guadeloupe-PD and AP patient groups. Montreal-AP patients displayed elevated monocyte percentages; proportions of monocytes and classical monocytes correlated with clinical scores in this patient group. Our study highlights immune differences related to disease type (PD vs. AP) and geographical location (Guadeloupe vs. Montreal), particularly in AP patients. A better understanding of the impact of environmental factors and age-related changes on the peripheral immune system of PD and AP patients could provide essential information to slow down and treat these conditions. Graphical Abstract The alternative text for this image may have been generated using AI.Keywords
This publication has 73 references indexed in Scilit:
- Nigral Neuroinflammation and Dopaminergic Neurons in Parkinson's Disease and Atypical ParkinsonismsAnnals of Neurology, 2025
- Ethnic Differences in Atypical Parkinsonism—is South Asian PSP Different?Movement Disorders Clinical Practice, 2024
- Peripheral Inflammatory and Immune Landscape in Multiple System Atrophy: A Cross‐Sectional StudyMovement Disorders, 2023
- Annonaceae Consumption Worsens Disease Severity and Cognitive Deficits in Degenerative ParkinsonismMovement Disorders, 2022
- The Movement Disorder Society Criteria for the Diagnosis of Multiple System AtrophyMovement Disorders, 2022
- The IL‐27/IL‐27R axis is altered in CD4+ and CD8+ T lymphocytes from multiple sclerosis patientsClinical & Translational Immunology, 2021
- Tracing the genetic legacy in the French Caribbean islands: A study of mitochondrial and Y‐chromosome lineages in the Guadeloupe archipelagoAmerican Journal of Physical Anthropology, 2019
- Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteriaMovement Disorders, 2017
- MDS clinical diagnostic criteria for Parkinson's diseaseMovement Disorders, 2015
- Atypical parkinsonism in the Caribbean island of Guadeloupe: Etiological role of the mitochondrial complex I inhibitor annonacinMovement Disorders, 2008